However, the upregulation of pro-angiogenic genes under the IP3-sponge-NLS treatment, which might indicate a compensatory tumor behavior, is not able to counteract the angiostatic effect of the observed CXCL10 overexpression; the only gene found in our pathway analysis associated with tumor angiogenesis blockage. Here, CXCL10 is linked to neoplasm.